DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 294.99%9.34M | 418.61%7.34M | 2,987.12%10.06M | 93.40%-3.04M | 130.45%3.73M | 77.89%-4.79M | 82.34%-2.31M | -64.33%326K | -66.75%-46.07M | -18.24%-12.26M |
Net income from continuing operations | 46.96%-2.57M | 92.06%-738K | 76.91%-2.73M | 64.89%-29.37M | 77.28%-3.41M | 76.95%-4.84M | 57.88%-9.29M | 53.79%-11.83M | -21.28%-83.66M | 37.01%-15M |
Operating gains losses | -210.00%-22K | -13.33%26K | 208.00%27K | 67.90%-52K | 84.69%-77K | -83.47%20K | -86.11%30K | -725.00%-25K | -604.35%-162K | -9,960.00%-503K |
Depreciation and amortization | 11.53%2.87M | 1.83%2.62M | -0.79%2.52M | -3.08%10.26M | 3.96%2.57M | 9.43%2.58M | -5.06%2.57M | -16.69%2.54M | 234.20%10.58M | 60.62%2.47M |
Other non cash items | -176.67%-677K | -65.26%230K | 14.01%236K | 48.02%1.65M | 65.47%-106K | 213.12%883K | -26.93%662K | -10.39%207K | 14,000.00%1.11M | -223.29%-307K |
Change In working capital | 165.20%5.23M | 177.62%749K | 17.06%5.89M | -140.15%-3.64M | 112.50%312K | 3.16%-8.02M | -331.41%-965K | -74.13%5.03M | -66.45%9.08M | -129.92%-2.5M |
-Change in receivables | 269.17%3.74M | -47.36%2.63M | 985.87%6.99M | -41.35%-9.73M | -0.53%-13.15M | -218.61%-2.21M | 29.69%4.99M | 32.51%644K | -34.10%-6.88M | -118.51%-13.08M |
-Change in payables and accrued expense | 39.74%5.54M | -156.99%-799K | -132.58%-2.46M | 129.30%1.26M | -111.50%-3.05M | 193.49%3.97M | 1,623.91%1.4M | -170.88%-1.06M | -164.61%-4.28M | -180.49%-1.44M |
-Change in other current assets | 407.12%2.2M | -38.02%-1.58M | -289.57%-1.29M | -67.09%564K | 81.75%1.74M | -158.74%-716K | 27.04%-1.14M | -38.32%681K | 128.72%1.71M | 115.88%959K |
-Change in other current liabilities | 260.88%2.64M | 113.16%245K | 8.21%-2.48M | 231.66%2.39M | 1,331.09%8.59M | 54.76%-1.64M | -2,214.77%-1.86M | -211.55%-2.7M | -113.26%-1.81M | -111.90%-698K |
-Change in other working capital | -19.91%-8.89M | 105.88%256K | -31.30%5.13M | -90.77%1.88M | -47.49%6.18M | -112.10%-7.42M | -134.18%-4.35M | -46.39%7.47M | 13.97%20.34M | 17.74%11.77M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 294.99%9.34M | 418.61%7.34M | 2,987.12%10.06M | 93.40%-3.04M | 130.45%3.73M | 77.89%-4.79M | 82.34%-2.31M | -64.33%326K | -66.75%-46.07M | -18.24%-12.26M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -6,468.09%-12.35M | -130.80%-1.15M | -169.79%-4.34M | 92.17%-2.59M | 84.37%-289K | 97.10%-188K | 97.44%-500K | 68.77%-1.61M | -548.49%-33.01M | 90.72%-1.85M |
Capital expenditure reported | -300.00%-324K | -71.17%-469K | --0 | 71.87%-821K | 92.22%-33K | 92.77%-81K | 72.46%-274K | -13.95%-433K | -481.47%-2.92M | -54.74%-424K |
Net PPE purchase and sale | -367.74%-290K | -195.08%-540K | 67.84%-364K | 94.48%-1.56M | 90.58%-182K | 99.08%-62K | 98.77%-183K | 76.34%-1.13M | -1,122.72%-28.26M | -115.63%-1.93M |
Net intangibles purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Net business purchase and sale | ---11.61M | ---24K | ---3.81M | --0 | --0 | --0 | --0 | --0 | 63.26%-3.49M | --0 |
Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Net other investing changes | -177.78%-125K | -181.40%-121K | -281.82%-168K | -112.41%-206K | -114.60%-74K | -104.30%-45K | -145.74%-43K | -466.67%-44K | 116.57%1.66M | 105.20%507K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -6,468.09%-12.35M | -130.80%-1.15M | -169.79%-4.34M | 92.17%-2.59M | 84.37%-289K | 97.10%-188K | 97.44%-500K | 68.77%-1.61M | -548.49%-33.01M | 90.72%-1.85M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 126.10%667K | -14.30%941K | -2,199.59%-22.33M | -95.91%1.19M | -21.35%770K | -98.83%295K | -53.98%1.1M | -259.44%-971K | -76.75%29.12M | 157.63%979K |
Net issuance payments of debt | --0 | --0 | ---25M | --0 | --0 | --0 | --0 | --0 | 192.90%25M | --0 |
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Proceeds from stock option exercised by employees | 126.10%667K | -14.30%941K | 91.88%2.67M | -13.65%3.56M | -21.35%770K | 106.29%295K | -53.98%1.1M | 128.57%1.39M | 236.91%4.12M | 98.98%979K |
Net other financing activities | ---- | ---- | ---- | ---2.36M | --0 | ---- | ---- | ---2.36M | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 126.10%667K | -14.30%941K | -2,199.59%-22.33M | -95.91%1.19M | -21.35%770K | -98.83%295K | -53.98%1.1M | -259.44%-971K | -76.75%29.12M | 157.63%979K |
Net cash flow | ||||||||||
Beginning cash position | -15.33%61.79M | -27.15%54.89M | -7.81%71.73M | -39.63%77.81M | -25.62%67.41M | -22.30%72.98M | -39.73%75.35M | -39.63%77.81M | 438.27%128.88M | -43.02%90.63M |
Current changes in cash | 50.12%-2.34M | 517.75%7.13M | -636.73%-16.61M | 91.13%-4.43M | 132.09%4.21M | -55.65%-4.69M | 94.35%-1.71M | 37.89%-2.25M | -147.59%-49.96M | 56.12%-13.13M |
Effect of exchange rate changes | 176.67%677K | 65.26%-230K | -14.01%-236K | -48.02%-1.65M | -65.47%106K | -213.12%-883K | 26.93%-662K | 10.39%-207K | -2,371.11%-1.11M | 223.29%307K |
End cash Position | -10.80%60.13M | -15.33%61.79M | -27.15%54.89M | -7.81%71.73M | -7.81%71.73M | -25.62%67.41M | -22.30%72.98M | -39.73%75.35M | -39.63%77.81M | -39.63%77.81M |
Free cash flow | 276.90%8.73M | 329.36%6.34M | 882.89%9.7M | 92.99%-5.42M | 124.07%3.52M | 83.27%-4.94M | 90.44%-2.76M | 70.85%-1.24M | -151.29%-77.24M | -26.67%-14.62M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |